Modern skin is caught in a cycle of sensitivity. In today’s world, constant exposure to UV radiation, pollution, and aesthetic procedures can weaken the skin’s barrier and disturb its microbiome, setting off a cycle of imbalance, inflammation, and redness. When resilience is compromised, skin falls behind. In contrast, skin that can adapt, restore balance, and recover efficiently remains healthy-looking for longer.
Human Milk Oligosaccharides (HMOs) are unique sugar molecules naturally present in mother’s milk. They program the resilience that equips newborns to adapt, recover, and thrive.
To address this growing challenge, dsm-firmenich brings a new frontier of biotechnology to skincare with GLYCARE® SK range, powered by Human Milk Oligosaccharide (HMO) technology, a science that was recognized with a scientific award at PCHi China 2026.
Using precision fermentation, dsm-firmenich replicates the exact bioidentical structures found in mother’s milk — without any human-derived materials — enabling the benefits of HMOs to be applied in cosmetic formulations.
By translating HMO biology into skincare, GLYCARE® SK can help activate the skin’s natural regenerative processes, strengthen the skin barrier, enhance resilience to inflammation and support smart microbiome adhesion.
Source: dsm-firmenich
